What is Pegcetacoplan (Intraocular Route): Uses, Dosage, Side Effects and More

Pegcetacoplan is a specialized eye medication that helps treat a serious eye condition called geographic atrophy. This medication works by blocking certain immune system proteins that can damage the retina, the light-sensitive tissue at the back of your eye that helps you see clearly.

If your doctor has mentioned pegcetacoplan, you're likely dealing with advanced dry age-related macular degeneration (AMD). This can feel overwhelming, but understanding how this treatment works can help you feel more confident about your care journey.

What is Pegcetacoplan?

Pegcetacoplan is a complement inhibitor medication specifically designed for injection into the eye. It targets proteins in your immune system called C3 and C5 that can cause inflammation and damage to your retinal cells when they become overactive.

The medication comes as a clear solution that your eye doctor injects directly into the vitreous, the gel-like substance inside your eye. This targeted approach allows the medicine to work exactly where it's needed most. You might hear your doctor refer to it by its brand name, Syfovre, which is the commercial form approved for treating geographic atrophy.

What is Pegcetacoplan Used For?

Pegcetacoplan treats geographic atrophy, a progressive form of dry age-related macular degeneration. Geographic atrophy creates areas of cell death in your macula, the central part of your retina responsible for sharp, detailed vision.

This condition typically affects people over 60 and can make reading, driving, and recognizing faces increasingly difficult. The medication helps slow the progression of geographic atrophy, potentially preserving more of your remaining vision over time. While it cannot restore vision you've already lost, it may help protect what you still have.

Your doctor might recommend this treatment if you have clearly defined geographic atrophy lesions and adequate remaining vision to benefit from slowing the disease's progression.

How Does Pegcetacoplan Work?

Pegcetacoplan works by blocking complement proteins that contribute to retinal cell damage. Your complement system is part of your immune system that normally helps fight infections, but in geographic atrophy, it becomes overactive and starts attacking healthy retinal cells.

Think of it like having an overzealous security system that starts attacking your own home instead of protecting it. The medication acts like a smart control system that tells the security system to calm down and stop the unnecessary damage.

This is considered a moderately strong medication because it directly modifies immune system activity. The effects are localized to your eye, which helps minimize systemic side effects while providing targeted protection for your retinal cells.

How Should I Take Pegcetacoplan?

Pegcetacoplan is administered only by your eye doctor through injection into your eye. You cannot take this medication at home - it requires professional administration in a clinical setting.

Before your injection appointment, you don't need to avoid food or drinks, but you should arrange for someone to drive you home afterward. Your eye will be numbed with topical anesthetic drops, and the injection itself takes just a few seconds. You might feel slight pressure during the injection, but it shouldn't be painful.

After the injection, your doctor will monitor you briefly to ensure there are no immediate complications. You can typically resume normal activities the same day, though your vision might be slightly blurry for a few hours as the numbing drops wear off.

How Long Should I Take Pegcetacoplan For?

Pegcetacoplan is typically given as ongoing treatment with injections scheduled every 25 to 60 days. Your doctor will determine the exact timing based on your individual response and the progression of your condition.

Geographic atrophy is a chronic, progressive condition, so treatment usually continues long-term to maintain its protective effects. Some patients may receive injections for years, while others might have treatment adjusted based on how their condition responds.

Your eye doctor will regularly monitor your vision and take detailed photographs of your retina to track whether the treatment is helping slow progression. If you're not seeing benefit after several months, or if side effects become concerning, your doctor might discuss adjusting your treatment plan.

What Are the Side Effects of Pegcetacoplan?

Like all medications, pegcetacoplan can cause side effects, though many people tolerate it well. Most side effects are related to the injection procedure itself rather than the medication's systemic effects.

Common side effects you might experience include temporary eye discomfort, mild eye redness, or small spots in your vision that usually resolve within a few days. These effects typically occur immediately after injection and improve as your eye heals.

More serious but less common side effects include:

• Eye infection (endophthalmitis), which can cause severe pain, vision loss, and discharge
• Retinal detachment, causing sudden vision changes or flashing lights
• Significant increase in eye pressure
• Severe inflammation inside the eye

Rare but serious complications can include severe vision loss or blindness, though these occur in less than 1% of patients. Your doctor carefully weighs these risks against the potential benefits of slowing your geographic atrophy progression.

Contact your eye doctor immediately if you experience severe eye pain, sudden vision changes, increasing redness, or any discharge from your eye after an injection.

Who Should Not Take Pegcetacoplan?

Pegcetacoplan isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for you. You should not receive this medication if you have an active eye infection or inflammation in or around the eye being treated.

People with certain immune system conditions or those taking specific immunosuppressive medications may not be good candidates for this treatment. Your doctor will also consider your overall health status and any other eye conditions you might have.

If you're pregnant or planning to become pregnant, discuss this with your doctor, as the safety of pegcetacoplan during pregnancy hasn't been established. Similarly, if you're breastfeeding, your doctor will help you weigh the potential benefits against any possible risks.

Patients with severe vision loss or very advanced geographic atrophy may not benefit significantly from treatment, and your doctor will help determine if the potential benefits justify the risks in your specific situation.

Pegcetacoplan Brand Name

Pegcetacoplan is sold under the brand name Syfovre. This is the only commercially available form of pegcetacoplan approved for treating geographic atrophy.

Syfovre is manufactured by Apellis Pharmaceuticals and was approved by the FDA in 2023. When discussing your treatment with insurance companies or scheduling appointments, you might hear your doctor refer to it by either name - pegcetacoplan or Syfovre.

The medication comes in pre-filled syringes designed for single use, ensuring consistent dosing and sterility for each injection.

Pegcetacoplan Alternatives

Currently, there are limited alternatives to pegcetacoplan for treating geographic atrophy. Traditional dry AMD treatments focus on nutritional supplements and lifestyle modifications rather than direct medical interventions.

AREDS2 supplements, which contain vitamins C and E, zinc, copper, lutein, and zeaxanthin, may help slow progression of intermediate dry AMD but are less effective for advanced geographic atrophy. Some patients use these supplements alongside pegcetacoplan treatment.

Avacincaptad pegol (Izervay) is another complement inhibitor that was approved around the same time as pegcetacoplan. It works similarly by targeting the complement system but has a different injection schedule and side effect profile.

Your doctor will help you understand which treatment option might work best for your specific situation, considering factors like your injection tolerance, lifestyle, and the pattern of your geographic atrophy.

Is Pegcetacoplan Better Than Avacincaptad Pegol?

Both pegcetacoplan and avacincaptad pegol are effective treatments for geographic atrophy, but they have different characteristics that might make one more suitable for you than the other.

Pegcetacoplan is typically injected every 25-60 days, while avacincaptad pegol is given monthly. Some patients prefer less frequent injections, while others find a predictable monthly schedule easier to manage.

The side effect profiles are similar between the two medications, though individual responses can vary. Both carry similar risks of serious complications like eye infection or retinal detachment.

Your eye doctor will consider factors like your specific type of geographic atrophy, your ability to attend regular appointments, and your personal preferences when recommending which medication might work better for you. Neither is universally "better" - the best choice depends on your individual circumstances.